BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Diagnosis
92 results:

  • 1. ABERRANT METHYLATION OF cancer-RELATED GENES IN VIETNAMESE breast cancer PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.
    Dieu Vuong L; Ngoc Nguyen Q
    Exp Oncol; 2023 Oct; 45(2):195-202. PubMed ID: 37824772
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Causes and consequences of delayed diagnosis in breast cancer screening with a focus on mammographic features and tumour characteristics.
    van der Veer EL; Lameijer J; Coolen AMP; Bluekens AMJ; Nederend J; Gielens M; Voogd A; Duijm L
    Eur J Radiol; 2023 Oct; 167():111048. PubMed ID: 37634439
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
    Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
    Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
    Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Strong Hereditary Predispositions to Colorectal cancer.
    Hryhorowicz S; Kaczmarek-Ryś M; Lis-Tanaś E; Porowski J; Szuman M; Grot N; Kryszczyńska A; Paszkowski J; Banasiewicz T; Pławski A
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553592
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ
    Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer.
    Rah B; Banday MA; Bhat GR; Shah OJ; Jeelani H; Kawoosa F; Yousuf T; Afroze D
    World J Gastroenterol; 2021 Sep; 27(36):6093-6109. PubMed ID: 34629822
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hereditary pancreatic cancer.
    Abe K; Kitago M; Kitagawa Y; Hirasawa A
    Int J Clin Oncol; 2021 Oct; 26(10):1784-1792. PubMed ID: 34476650
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Case-case analysis addressing ascertainment bias for multigene panel testing implicates BRCA1 and PALB2 in endometrial cancer.
    Johnatty SE; Pesaran T; Dolinsky J; Yussuf A; LaDuca H; James PA; O'Mara TA; Spurdle AB
    Hum Mutat; 2021 Oct; 42(10):1265-1278. PubMed ID: 34245638
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The contribution of Lynch syndrome to early onset malignancy in Ireland.
    Talbot A; O'Donovan E; Berkley E; Nolan C; Clarke R; Gallagher D
    BMC Cancer; 2021 May; 21(1):617. PubMed ID: 34039291
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Co-occurrence of germline pathogenic variants for different hereditary cancer syndromes in patients with Lynch syndrome.
    Ferrer-Avargues R; Castillejo MI; Dámaso E; Díez-Obrero V; Garrigos N; Molina T; Codoñer-Alejos A; Segura Á; Sánchez-Heras AB; Castillejo A; Soto JL
    Cancer Commun (Lond); 2021 Mar; 41(3):218-228. PubMed ID: 33630411
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predicted Chemotherapy Benefit for breast cancer Patients With Germline Pathogenic Variants in cancer Susceptibility Genes.
    Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The diagnostic value of DNA repair gene in breast cancer metastasis.
    Yang Y; Li X; Hao L; Jiang D; Wu B; He T; Tang Y
    Sci Rep; 2020 Nov; 10(1):19626. PubMed ID: 33184404
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Feedback of extended panel sequencing in 1530 patients referred for suspicion of hereditary predisposition to adult cancers.
    Cavaillé M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Gay-Bellile M; Lepage M; Viala S; Bidet Y; Bignon YJ
    Clin Genet; 2021 Jan; 99(1):166-175. PubMed ID: 33047316
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
    Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
    Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Easy One-Step Amplification and Labeling Procedure for Copy Number Variation Detection.
    Blesa S; Olivares MD; Alic AS; Serrano A; Lendinez V; González-Albert V; Olivares L; Martínez-Hervás S; Juanes JM; Marín P; Real JT; Navarro B; García-García AB; Chaves FJ; Ivorra C
    Clin Chem; 2020 Mar; 66(3):463-473. PubMed ID: 32068788
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
    da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
    BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients.
    Gervas P; Klyuch B; Denisov E; Kiselev A; Molokov A; Pisareva L; Malinovskaya E; Choynzonov E; Cherdyntseva N
    Mol Biol Rep; 2019 Oct; 46(5):5537-5541. PubMed ID: 31273614
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNA Methylation Profiles and Their Diagnostic Utility in BC.
    Shan M; Zhang L; Liu Y; Gao C; Kang W; Yang W; He Y; Zhang G
    Dis Markers; 2019; 2019():6328503. PubMed ID: 31198475
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
    Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
    Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.